141 related articles for article (PubMed ID: 34439284)
1. Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients.
Usai A; Di Franco G; Piccardi M; Cateni P; Pollina LE; Vivaldi C; Vasile E; Funel N; Palmeri M; Dente L; Falcone A; Giunchi D; Massolo A; Raffa V; Morelli L
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439284
[TBL] [Abstract][Full Text] [Related]
2. Zebrafish Patient-Derived Xenograft Model to Predict Treatment Outcomes of Colorectal Cancer Patients.
Di Franco G; Usai A; Piccardi M; Cateni P; Palmeri M; Pollina LE; Gaeta R; Marmorino F; Cremolini C; Dente L; Massolo A; Raffa V; Morelli L
Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884780
[TBL] [Abstract][Full Text] [Related]
3. Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine.
Di Franco G; Usai A; Funel N; Palmeri M; Montesanti IER; Bianchini M; Gianardi D; Furbetta N; Guadagni S; Vasile E; Falcone A; Pollina LE; Raffa V; Morelli L
World J Gastroenterol; 2020 Jun; 26(21):2792-2809. PubMed ID: 32550755
[TBL] [Abstract][Full Text] [Related]
4. A Model of a Zebrafish Avatar for Co-Clinical Trials.
Usai A; Di Franco G; Colucci P; Pollina LE; Vasile E; Funel N; Palmeri M; Dente L; Falcone A; Morelli L; Raffa V
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183229
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment.
Wang L; Chen H; Fei F; He X; Sun S; Lv K; Yu B; Long J; Wang X
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31107449
[TBL] [Abstract][Full Text] [Related]
6. Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts.
Fior R; Póvoa V; Mendes RV; Carvalho T; Gomes A; Figueiredo N; Ferreira MG
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8234-E8243. PubMed ID: 28835536
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer.
Wu JQ; Zhai J; Li CY; Tan AM; Wei P; Shen LZ; He MF
J Exp Clin Cancer Res; 2017 Nov; 36(1):160. PubMed ID: 29141689
[TBL] [Abstract][Full Text] [Related]
8. Assessment of stromal SCD-induced drug resistance of PDAC using 3D-printed zPDX model chips.
Wu C; Hu B; Wang L; Wu X; Gu H; Dong H; Yan J; Qi Z; Zhang Q; Chen H; Yu B; Hu S; Qian Y; Dong S; Li Q; Wang X; Long J
iScience; 2023 Jan; 26(1):105723. PubMed ID: 36590169
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pancreatic cancer: challenge of the facts.
Beger HG; Rau B; Gansauge F; Poch B; Link KH
World J Surg; 2003 Oct; 27(10):1075-84. PubMed ID: 12925907
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models.
Hoare O; Fraunhoffer N; Elkaoutari A; Gayet O; Bigonnet M; Roques J; Nicolle R; McGuckin C; Forraz N; Sohier E; Tonon L; Wajda P; Boyault S; Attignon V; Tabone-Eglinger S; Barbier S; Mignard C; Duchamp O; Iovanna J; Dusetti NJ
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069519
[No Abstract] [Full Text] [Related]
11. Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models.
Gatzweiler C; Ridinger J; Herter S; Gerloff XF; ElHarouni D; Berker Y; Imle R; Schmitt L; Kreth S; Stainczyk S; Ayhan S; Najafi S; Krunic D; Frese K; Meder B; Reuss D; Fiesel P; Schramm K; Blattner-Johnson M; Jones DTW; Banito A; Westermann F; Oppermann S; Milde T; Peterziel H; Witt O; Oehme I
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159116
[TBL] [Abstract][Full Text] [Related]
12. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment.
Wong CW; Han HW; Tien YW; Hsu SH
Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644
[TBL] [Abstract][Full Text] [Related]
13. Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer.
Chang SC; Hsu CP; Tsai CY; Liu YY; Liu KH; Hsu JT; Yeh TS; Yeh CN; Hwang TL
Medicine (Baltimore); 2016 Jul; 95(30):e4191. PubMed ID: 27472688
[TBL] [Abstract][Full Text] [Related]
14. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
[TBL] [Abstract][Full Text] [Related]
15. Establishment of Zebrafish Patient-derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing.
Usai A; Di Franco G; Gabellini C; Morelli L; Raffa V
J Vis Exp; 2023 May; (195):. PubMed ID: 37246888
[TBL] [Abstract][Full Text] [Related]
16. New challenges in perioperative management of pancreatic cancer.
Puleo F; Maréchal R; Demetter P; Bali MA; Calomme A; Closset J; Bachet JB; Deviere J; Van Laethem JL
World J Gastroenterol; 2015 Feb; 21(8):2281-93. PubMed ID: 25741134
[TBL] [Abstract][Full Text] [Related]
17. Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients.
Aoki S; Motoi F; Murakami Y; Sho M; Satoi S; Honda G; Uemura K; Okada KI; Matsumoto I; Nagai M; Yanagimoto H; Kurata M; Fukumoto T; Mizuma M; Yamaue H; Unno M;
BMC Cancer; 2019 Mar; 19(1):252. PubMed ID: 30898101
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
19. Zebrafish Cancer Avatars: A Translational Platform for Analyzing Tumor Heterogeneity and Predicting Patient Outcomes.
Al-Hamaly MA; Turner LT; Rivera-Martinez A; Rodriguez A; Blackburn JS
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768609
[TBL] [Abstract][Full Text] [Related]
20. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
